Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Editorials

Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease

Bone Marrow Transplantation Unit, Hospital Británico, Buenos Aires, Argentina; Clinical Hematology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona
Clinical Hematology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain; IDIBELL Research Institute, Hospitalet de Llobregat, Barcelona
Clinical Hematology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain; IDIBELL Research Institute, Hospitalet de Llobregat, Barcelona, Spain; University of Barcelona, Barcelona
Haematologica Early view Sep 25, 2025 https://doi.org/10.3324/haematol.2025.288307

Abstract

Not available.

Figures & Tables

Article Information

Early view : Editorials
 
DOI
https://doi.org/10.3324/haematol.2025.288307
Pubmed
40994362
 
Published
2025-09-25
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
292
PDF Downloads
97

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online